Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms UNC6846 |
Target |
Mechanism EED inhibitors(Polycomb protein EED inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC47H56N10O9S |
InChIKeyMKRMIGNBGFQRAG-LFHXYJAASA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | US | 01 Jan 2020 |